3580 results for «259»
3580 results
PCR Valves e-Course 2020 best mitral and tricuspid cases
23 Nov 2020 – From PCR Valves e-Course 2020
- Percutaneous closure of prosthetic mitral PVL: anchoring balloon to facilitate procedure. A. Sardone, Italy
- Successful repeated TMVR after late prosthesis failure - ViViV procedure for failed mitral bioprosthesis. E. Xhepa, Germany
- Synergistic effect of 2 transcatheter tricuspid valve treatment modalities. N. Corpataux, F. Praz, Switzerland
- Transcatheter treatment of severe...
PCR Valves e-Course 2020 best TAVI cases - session II
22 Nov 2020 – From PCR Valves e-Course 2020
- TAVI in stentless bioprosthesis: how to protect the coronaries. P. Dardas, Greece
- Intravascular lithotripsy-assisted balloon angioplasty to facilitate transfemoral TAVI. J. Morris, Ireland
- Management of RV pseudoaneurism after transcatheter tricuspid ViV implantation. C. Reddavid, Italy
- First-in-man use of the next-generation ProtEmbo cerebral embolic protection system during transcatheter aortic ViV...
Approach to calcified coronary lesions in a complex patient
12 Dec 2020 – From GulfPCR-GIM 2020
Watch this session if you want to recognise the need for plaque modification in calcified coronary lesions to enable optimal stent deployment, to discuss the different plaque modification strategies available and to see the step-wise approach to calcified lesions with a simplified algorithm.
This session was originally...
CAD management in TAVI patients
12 Dec 2020 – From GulfPCR-GIM 2020
Watch this session if you want to reflect on optimal management of CAD in TAVI candidates, to discuss tips and tricks to improve future coronary access during TAVI procedure and to review how to optimise management of CAD in post-TAVI patients.
This session was originally presented during...
The year in review in Interventional Cardiology: clinical trials and relevant literature published in 2020
12 Dec 2020 – From GulfPCR-GIM 2020
Watch this session if you want to reflect on key learnings for clinical practice from selected trials published in 2020, to get a rapid overview of the most relevant literature of the year in the fields of coronary, valvular and peripheral interventions and to see examples...
PCR Valves e-Course 2020 best TAVI cases - session I
22 Nov 2020 – From PCR Valves e-Course 2020
- Hybrid coronary protection in ViV TAVI with BASILICA and chimney techniques. M. Pighi, Italy
- Transcatheter closure of a LV pseudoaneurysm after transapical ViV TAVI. E. Garau, Italy
- Anterograde crossing of a bicuspid aortic valve to facilitate TAVI. B. Bawamia, United Kingdom
- Coronary protection with BASILICA technique and IVUS, followed...
PCR Valves e-Course 2020 best innovations
24 Nov 2020 – From PCR Valves e-Course 2020
- Treatment of MR: physiological annulus downsizing with an innovative helix ring. Long-term results with surgical model and mid-term results with transcatheter model. K. Kervinen, Finland
- First-in-man experience with a single-piece, durable aortic valve therapy. B. Meuris, Belgium
- First-in-man experience of CroíValve Duo a novel percutaneous transcatheter tricuspid coaptation...
Multi-modality imaging for transcatheter tricuspid valve interventions
23 Nov 2020 – From PCR Valves e-Course 2020
Watch this session if you want to appreciate how cardiac chamber views can be used to create a common language across imaging modalities and to understand the relationship between cardiac chamber views and optimal projection curves (S-curves).
This session was originally presented during PCR Valves e-Course 2020.
Multi-modality imaging for transcatheter aortic valve interventions (TAVI)
24 Nov 2020 – From PCR Valves e-Course 2020
Watch this session if you want to understand the relationship between cardiac chamber views and optimal projection curves (S-curves) and to learn how to apply cardiac chamber views and S-curves in transcatheter aortic valve interventions (TAVI / TAVR)
Evidence counts: latest data from Onyx one-month DAPT programme and renal denervation
12 Dec 2020 – From GulfPCR-GIM 2020
In this session you will get an overview of the subanalysis of Onyx One-month DAPT program which evaluated highly complex high-bleeding risk patients on one-month DAPT, followed by the latest evidence on renal denervation for the treatment of hypertension.
Robotic PCI and advancements in smart procedural automation
12 Dec 2020 – From GulfPCR-GIM 2020
A. Nooryani talks with J. Fajadet about the beginnings of robotic procedures in interventional cardiology in the United Arab Emirates and shares his experience using this new technology, demonstrating with cases.
Latest evidence on cardiogenic shock management
13 Dec 2020 – From AICT-AsiaPCR 2020
Find out more about the latest evidence on the management of cardiogenic shock followed by key messages to improve the outcome of very sick cardiogenic shock patients.
The future of hypertension management: another treatment option
13 Dec 2020 – From AICT-AsiaPCR 2020
Join A. Fong and Y-H. Lee as they share their experience on the management of hypertension and the latest information on renal denervation.
What you need to know about DAPT in high-bleeding risk patients
12 Dec 2020 – From GulfPCR-GIM 2020
This educational session focuses on the high-bleeding risk situation in the Gulf Region, the latest evidence on HBR and how to integrate it into your practice, followed by challenging cases discussed by Mirvat Alasnag,Thomas Cuisset, Marco Valgimigli and Peter Smits.
Advancement in bifurcation and renal denervation – The right procedure for the right patient?
13 Dec 2020 – From AICT-AsiaPCR 2020
Watch this session to learn more about how and when to select DK crush technique or provisional stenting in bifurcation cases, the pros and cons of both techniques, as well as patient selection for renal denervation in the treatment of uncontrolled hypertension.
PCR Valves e-Course 2020 Hotline - ACTIVATION trial, NIUT in patients with severe symptomatic calcific aortic stenosis, CUTTING-EDGE registry...
22 Nov 2020 – From PCR Valves e-Course 2020
- The percutAneous Coronary inTervention prIor to trans-catheter aortic VAlve implantaTION trial. S. Redwood: ACTIVATION Trial. S. Redwood
- Prospective, single-arm clinical investigation for the safety and feasibility study of Valvosoft NIUT in patients with severe symptomatic calcific aortic stenosis - First-in-man. E. Messas
- Outcomes of mitral valve surgery after...
A journey with Charles Dotter: his contribution to transluminal angioplasty
In this interview, Chiara De Biase and Jean Marco embark on a journey through the history of interventional medicine, focusing on Charles Dotter, the pioneer of transluminal angioplasty, and Andreas Grüntzig.
In this first episode, they discuss Dotter's groundbreaking contributions, including the first interventional transluminal angioplasty in 1964, which revolutionized...
First-in-human evaluation of a novel sirolimus-eluting ultra-high molecular weight APTITUDE bioresorbable scaffold: 9- and 24-month imaging and clinical results of the RENASCENT II trial
18 Jun 2020
The novel sirolimus-eluting ultra-high molecular weight APTITUDE bioreabsorbable vascular scaffold (BRS) displays higher mechanical strength, expansion capabilities and resistance to fracture compared to other BRS technologies. RENASCENT II is a prospective, multicentre first-in-human clinical study evaluating the clinical performance of the APTITUDE BRS in the treatment...
Authors :
Management of mitral regurgitation patients undergoing TMVI screening
13 Jan 2022
This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
07 Nov 2021
Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...
Author
Author
